FMP
Financial data for every need
We provide one of the most accurate financial data available on the market. You can get historical prices, fundamental data, insider transactions, and much more that goes back 30 years in history.
Get started
70,000+ Stocks with tons of data
Ready to Unlock Insights?
Welcome to our comprehensive suite of tools designed to streamline your financial data integration process.
API Documentation
Access user-friendly RESTful API documentation suitable for all skill levels.
Detailed endpoint documentation.
Clear request/response examples.
Streamlined navigation.
Ensures clarity/reliability.
API Viewer
Explore endpoints hassle-free with our code-free API Playground.
Interactive data tools.
User-friendly interface.
Download data in CSV/Excel.
Ideal for hands-on exploration.
Stock Prices
Real-time Prices, Historical Data and Indicators.
Stock Fundamentals
Financial Statements, Key Metrics, Stock Financial Scores and more.
Market News
Stock News, Press Releases and Experts Articles.
Company Information
Company Outlook, Market Capitalization, Company Core Information.
Data is collected only from trusted sources
Quality data is key to making accurate, informed decisions. All our data is licensed and sourced from curated third-party data partners, such as the U.S. Securities and Exchange Commission (SEC), Board of Governors of the Federal Reserve System.
See DocumentationFast, accurate, and developer friendly
We provide one of the most accurate data available on the market. We spent years designing endpoints and made them informative, well-documented, and easy to use.
Our API has over 100 endpoints and we are still growing and adding new endpoints every week. Every endpoint is available in JSON format and most of them also in CSV format.
We also provide on demand custom endpoint available for our enterprise plan.
See documentation
Trusted by 100,000+ customers
Join us and get your API key
Latest News
Stay Updated and Harness the Power of Our API with the Latest News!
Jun 30, 2025 3:00 PM - Alex Lavoie
Hewlett Packard Enterprise Co (NYSE:HPE) Strategic Moves and Market Impact
Hewlett Packard Enterprise Co (NYSE:HPE) is a global technology company that provides solutions in IT infrastructure, software, and services. It competes with major players like Cisco Systems in the networking and server markets. Recently, Bank of America Securities maintained a "Buy" rating for HPE...
Jun 30, 2025 2:00 PM - Gordon Thompson
The Greenbrier Companies: A Pillar in Global Freight Transportation
The Greenbrier Companies, trading on the NYSE under the symbol GBX, is a key player in the global freight transportation market. Headquartered in Lake Oswego, Oregon, Greenbrier designs, builds, and markets freight railcars across North America, Europe, and Brazil. The company also provides essentia...
Jun 30, 2025 11:34 AM - Davit Kirakosyan
Oppenheimer Lifts DoorDash Target to $280 on Strong Growth and Profit Upside
Oppenheimer raised its price target on DoorDash (NASDAQ:DASH) to $280 from $220 while maintaining an Outperform rating, citing accelerating profitability and stronger-than-expected data on order volumes and advertising revenue. The firm highlighted DoorDash’s recent disclosure of $1 billion in adver...
Jun 30, 2025 11:31 AM - Davit Kirakosyan
Mizuho Upgrades Consolidated Edison to Outperform, Sees Selloff as Buying Opportunity
Mizuho upgraded Consolidated Edison (NYSE:ED) to Outperform from Neutral, raising its price target to $107 from $105, arguing that the recent weakness in shares creates an attractive entry point for a premium utility stock. The firm noted that ED shares have underperformed the UTY index over the pas...
Jun 30, 2025 11:20 AM - Davit Kirakosyan
BofA Downgrades ProKidney to Underperform on Weaker REACT Outlook
BofA Securities downgraded ProKidney (NASDAQ:PROK) to Underperform from Neutral and cut its price target to $1 from $3, citing a sharply reduced outlook for the company’s sole drug candidate, REACT, targeting diabetic chronic kidney disease. As a result, the company’s shares fell over 10% intra-day ...
Jun 30, 2025 11:12 AM - Davit Kirakosyan
Citi Reiterates Buy on Cogent, Sees Big Upside Ahead of Key Trial Readout
Citi reaffirmed its Buy rating and $15 price target on Cogent Communications (NASDAQ:CCOI), highlighting a highly favorable risk/reward profile ahead of pivotal data expected in July from the registrational Part 2 of the Phase 2 SUMMIT trial testing bezuclastinib in non-advanced systemic mastocytosi...
Jun 30, 2025 11:10 AM - Davit Kirakosyan
Guggenheim Boosts Disney Target, Highlights Cost Efficiencies and DTC Strategy
Guggenheim raised its price target on Walt Disney (NYSE:DIS) to $140 from $120 while maintaining a Buy rating, pointing to stronger operating leverage, improving advertising trends, and a clearer path to unified direct-to-consumer (DTC) growth. The analysts cited refined expectations for Disney’s Li...
